Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048944 · ClinicalTrials.gov registry record · Phase 4
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
A Phase 4 study, sponsored by Southern Illinois University Carbondale.
- Completed
- Registry status
- Phase 4
- Development phase
- 197
- Enrollment target
NCT01048944 is a Phase 4 study that has completed, run by Southern Illinois University Carbondale. The registered enrollment target is 197 participants.
The verdict
NCT01048944, a Phase 4 study, has completed, sponsored by Southern Illinois University Carbondale.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to better characterize differences in mood, attention, brain activation patterns underlying the beneficial effects of pharmacological treatments previously demonstrated to be help individuals successfully quit tobacco smoking. Smokers will be randomly assigned to one of three treatments: 1) bupropion sustained release (SR), 2) nicotine patch, or 3) placebo patches plus pills across a 45-day period with a 3-week intensive post-treatment follow-up. In addition, 20 percent of the subjects will be randomized to a delayed-quit control group.
Interventions
- DRUG Nicotine Patch
- DRUG Bupropion SR
- DRUG Placebo Patch and Placebo Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2005-06 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01048944
The ClinicalTrials.gov registry entry for NCT01048944 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University Carbondale, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT01048944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01048944 about?
NCT01048944 is a clinical study titled "Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers". The purpose of this study is to better characterize differences in mood, attention, brain activation patterns underlying the beneficial effects of pharmacological treatments previously demonstrated to be help individuals successfully quit tobacco smoking. Smokers will be randomly assigned to one of ...
What is the current status of trial NCT01048944?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 197 participants. The study started on 2005-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01048944?
The interventions under investigation include: Nicotine Patch (DRUG), Bupropion SR (DRUG), Placebo Patch and Placebo Pill (DRUG).
Who is sponsoring clinical trial NCT01048944?
This trial is sponsored by Southern Illinois University Carbondale, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.